Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3629425
Max Phase: Preclinical
Molecular Formula: C31H31N5O2
Molecular Weight: 505.62
Molecule Type: Small molecule
Associated Items:
ID: ALA3629425
Max Phase: Preclinical
Molecular Formula: C31H31N5O2
Molecular Weight: 505.62
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@@H](CO)Nc1nc(Oc2ccc3c(c2)CCC3)nc2c1ncn2Cc1ccc(-c2ccccc2)cc1
Standard InChI: InChI=1S/C31H31N5O2/c1-2-26(19-37)33-29-28-30(35-31(34-29)38-27-16-15-23-9-6-10-25(23)17-27)36(20-32-28)18-21-11-13-24(14-12-21)22-7-4-3-5-8-22/h3-5,7-8,11-17,20,26,37H,2,6,9-10,18-19H2,1H3,(H,33,34,35)/t26-/m0/s1
Standard InChI Key: GAHXYVXGHVFCJJ-SANMLTNESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 505.62 | Molecular Weight (Monoisotopic): 505.2478 | AlogP: 6.01 | #Rotatable Bonds: 9 |
Polar Surface Area: 85.09 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 2.84 | CX LogP: 6.80 | CX LogD: 6.80 |
Aromatic Rings: 5 | Heavy Atoms: 38 | QED Weighted: 0.26 | Np Likeness Score: -0.72 |
1. Singh MK, Gao H, Sun W, Song Z, Schmalzigaug R, Premont RT, Zhang Q.. (2015) Structure-activity relationship studies of QS11, a small molecule Wnt synergistic agonist., 25 (21): [PMID:26152429] [10.1016/j.bmcl.2015.06.062] |
Source(1):